Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neuphoria Therapeutics (NEUP) Other Non Operating Income (2024 - 2025)

Neuphoria Therapeutics (NEUP) has disclosed Other Non Operating Income for 2 consecutive years, with -$135659.0 as the latest value for Q4 2025.

  • Quarterly Other Non Operating Income fell 121.55% to -$135659.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$961854.0 through Dec 2025, changed N/A year-over-year, with the annual reading at -$414996.0 for FY2025, 118.8% down from the prior year.
  • Other Non Operating Income for Q4 2025 was -$135659.0 at Neuphoria Therapeutics, down from -$61735.0 in the prior quarter.
  • The five-year high for Other Non Operating Income was $629501.0 in Q4 2024, with the low at -$937406.0 in Q2 2025.